• Revamped current program analytics and create consistent methodologies and visualizations of value metrics for client accounts across a range of Lash services (Reimbursement, Co-Pay, Adherence, PAP, etc).• Designed plans for implementing client-focused program reviews of actionable insights.

•Developed Commercial HLS sales strategy focused on leveraging strong analytical expertise and industry experience to solve complex Payer and Commercial Pharma business challenges in the areas of omni-channel marketing optimization, real-world evidence development, forecasting, and managed markets contract effectiveness.

• Led cross-US Pharma initiative to create a consistent and objective approach to promotional budget allocation. • Key analytic lead for Launch pre-planning, execution, and post-assessment. Provide financial and strategy guidance and goal-setting benchmarks to Corporate leadership for upcoming launches.

• Spearheaded Payer Dashboard metric development, design, and rollout along with supplemental variance reporting for Leadership team. Linked metrics to Managed Care Incentive Compensation Design in collaboration with Payer Account teams and Incentive Compensation department. • Managed Payer Marketing Budget forecasting and reporting. Coordinated operational dimensions of the annual business plan budgeting process for the Payer Strategy team.• 1 of 50 participants selected from all of GSK US Pharma for participation in the 2011-12 Emerging Leader Development (ELD) Program.

Appointed to work with the Marketing Capabilities and Strategic Planning (GROW) workstream to determine short- and long-term process and ownership improvements to strategic planning to optimize customer insights as well as resource allocation decisions. Design statistical models for critical resourcing decisions. Some Examples: Linear and Logistic Regressions Cluster Analysis and Segmentation Predictive Targeting Unconstrained / Constrained Nonlinear Optimization Experimental DesignCollaborate with Primary Market Research, Channel Measurement, and Pharmacy Solutions Departments on primary and secondary data interpretation to develop brand/pharmacy strategies as well as evaluating the relative costs/benefits of the use of various outside vendors.Empowered Sales Training Division to quantify their value by developing a training-specific ROI measurement methodology.Created Footprint-Level Portfolio Resourcing Optimization Model to inform Salesforce and Brand Allocation Planning.Developed customized targeting and ROI analysis methodologies and sales force deployment strategies for HIV, NeuroHealth, and GI Divisions.Created a time-saving NeuroHealth Route Scheduling Tool that became the prototype for the final IT-created sales force routing tool.

Developed partial equilibrium models to estimate market-, industry-, social welfare impacts associated with air pollution.Assessed small entity impacts in accordance with requirements of the Small Business Regulatory Enforcement and Fairness Act (SBREFA).Created a database to evaluate the economic impacts of government use of voluntary compliance standards.Conducted the billing analysis for small commercial and industrial efficiency programs to estimate the realized energy savings using multivariate regression techniques.